Showing results (61-70 of 246) with videos related to

Sort By:
Pageof 25
The Oncologist|August 19, 2022
DLL3 as an Emerging Target for the Treatment of Neuroendocrine NeoplasmsJames Yao, Emily Bergsland, Rahul Aggarwal, et al.
Pharmaceuticals (Basel, Switzerland)|November 27, 2025
YM155 Inhibition of Survivin Enhances Carboplatin Efficacy in Metastatic Castration-Resistant Prostate CancerVicenç Ruiz de Porras, Martin K Bakht, Maria Fernandez-Saorín, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancerBeatriz German, Jagpreet N Singh, Marcos AdS Fonseca, et al.
European Urology|May 20, 2011
New therapies for castration-resistant prostate cancer: efficacy and safetyHimisha Beltran, Tomasz M Beer, Michael A Carducci, et al.
Molecular Cancer Research : MCR|June 24, 2024
Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate CancerSharon H Choi, Elizabeth Pan, Andrew Elliott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2023
Immunogenomic Landscape of Neuroendocrine Prostate CancerBhavneet Bhinder, Alison Ferguson, Michael Sigouros, et al.
Clinical Genitourinary Cancer|September 4, 2024
The Use of Lurbinectedin for the Treatment of Small Cell and Neuroendocrine Carcinoma of the ProstateHaley Meyer, Rajitha Sunkara, Emily Rothmann, et al.
Nature Communications|January 22, 2020
Androgen deprivation upregulates SPINK1 expression and potentiates cellular plasticity in prostate cancerRitika Tiwari, Nishat Manzar, Vipul Bhatia, et al.
Journal of Extracellular Vesicles|September 14, 2020
Small extracellular vesicles modulated by αVβ3 integrin induce neuroendocrine differentiation in recipient cancer cellsFabio Quaglia, Shiv Ram Krishn, George G Daaboul, et al.
Pageof 25